$Pinterest (PINS.US)$ Now that the year is basically behind us, I thought we could post our worst decisions from the past year. We could even learn something from each other!
I can go first: $PINS, down around ~35%. Not selling though, I like the fundamentals and I believe they can do well long-term.

$Virgin Galactic (SPCE.US)$ Virgin Galactic has gotten beaten down badly and rightfully so. They're getting investigated and every time Blue Origin has a successful launch, it makes SPCE look that much worse. They have tons of money left to burn, and they plan to have monthly launches starting January 2023. I bought shares with this one since the LEAPS don't offer attractive leverage and IV is very high. It can very well go back to the $30-50+ range, from the current $14 pri...

$Hims & Hers Health (HIMS.US)$ Hims&Hers is a tremendous healthcare brand. They only control 0.4% of a 75 Billion dollar market. They have a goal to hit 4% control within the coming years. I bought shares with this one, instead of LEAPS. It's very unfairly beaten down at $6 and people are starting to notice.

$Disney (DIS.US)$ Disney is a no-brainer IMO. When covid eventually settles, it's golden. But, what makes it so much more attractive is they've set a goal to bring their subscriber count for Disney+ from 110 Million to 250 Million by 2024. Bought 2024 LEAPS and they're already printing.

$Pfizer (PFE.US)$ $Moderna (MRNA.US)$ $BioNTech (BNTX.US)$ $Novavax (NVAX.US)$ $Valneva (VALN.US)$
Vaccine stocks ($MRNA, $BNTX, $NVAX, $VALN) generated impressive returns in 2021. However, they dumped in the last couple of weeks. For example $NVAX is down 40% since they approved their vaccine in mid Dec.
I think there will be much more pressure in 2022 since there is higher competition among them, plus more pills get approved, etc.
What are your...

$Rivian Automotive (RIVN.US)$ $NIO Inc (NIO.US)$ My read on the next year or two is that volatile stocks particularly growth stocks are more likely to blow up in a negative way rather than a positive way.

$Tesla (TSLA.US)$ Tesla “is in a clear position of strength heading into 2022,” according to analysts at Wedbush, who see three catalysts, including China demand, driving the stock higher. Wedbush has a current base price target on Tesla (ticker: TSLA) shares of $1,400 and a bull case target of $1,800. The Wedbush analysts, led by Dan Ives, wrote in a note they were maintaining their Outperform ra...

$EngageSmart (ESMT.US)$ ESMT - Healthcare focused CRM
$Upstart (UPST.US)$ UPST - trying to change loan origination by eliminating FICO, their auto expansion offers a lot of upside. Best of all, operating profitably already.
$SoFi Technologies (SOFI.US)$ SOFI - a leading Neobank, excellent CEO, looking well priced with bank charter coming up and will look even better if Chime IPOs at previously rumored valuations.
$Stem Inc (STEM.US)$ STEM - energy utilization/storage software.
$Genius Sports (GENI.US)$ GENI - da...